Andersons pediatric cardiology 1700
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.53 KB, 3 trang )
17.ChowEJ,ChenY,KremerLC,etal.Individual
predictionofheartfailureamongchildhood
cancersurvivors.JClinOncol.2015;33(5):394–
402.
18.MulrooneyDA,ArmstrongGT,HuangS,etal.
Cardiacoutcomesinadultsurvivorsof
childhoodcancerexposedtocardiotoxic
therapy:aCross-sectionalstudy.AnnIntern
Med.2016;164(2):93–101.
19.ArmenianSH,LacchettiC,BaracA,etal.
Preventionandmonitoringofcardiac
dysfunctioninsurvivorsofadultcancers:
Americansocietyofclinicaloncologyclinical
practiceguideline.JClinOncol.
2017;35(8):893–911.
20.BaracA,MurtaghG,CarverJR,etal.
Cardiovascularhealthofpatientswithcancer
andcancersurvivors:Aroadmaptothenext
level.JAmCollCardiol.2015;65(25):2739–
2746.
21.vanDalenEC,vandenBrugM,CaronHN,
KremerLC.Anthracycline-induced
cardiotoxicity:comparisonofrecommendations
formonitoringcardiacfunctionduringtherapy
inpaediatriconcologytrials.EurJCancer.
2006;42(18):3199–3205.
22.WongFL,BhatiaS,LandierW,etal.Cost-
effectivenessofthechildren'soncologygroup
long-termfollow-upscreeningguidelinesfor
childhoodcancersurvivorsatriskfortreatmentrelatedheartfailure.AnnInternMed.
2014;160(10):672–683.
23.CardinaleD,ColomboA,BacchianiG,etal.
Earlydetectionofanthracyclinecardiotoxicity
andimprovementwithheartfailuretherapy.
Circulation.2015;131(22):1981–1988.
24.CardinaleD,ColomboA,LamantiaG,etal.
Anthracycline-inducedcardiomyopathy:clinical
relevanceandresponsetopharmacologic
therapy.JAmCollCardiol.2010;55(3):213–
220.
25.PlanaJC,GalderisiM,BaracA,etal.Expert
consensusformultimodalityimagingevaluation
ofadultpatientsduringandaftercancertherapy:
areportfromtheAmericansocietyof
echocardiographyandtheEuropeanassociation
ofcardiovascularimaging.Journalofthe
AmericanSocietyofEchocardiography:official
publicationoftheAmericanSocietyof
Echocardiography.2014;27(9):911–939.
26.ThavendiranathanP,PoulinF,LimKD,etal.Use
ofmyocardialstrainimagingby
echocardiographyfortheearlydetectionof
cardiotoxicityinpatientsduringandaftercancer
chemotherapy:asystematicreview.JAmColl
Cardiol.2014;63(25PtA):2751–2768.
27.ArmstrongGT,PlanaJC,ZhangN,etal.
Screeningadultsurvivorsofchildhoodcancer
forcardiomyopathy:comparisonof
echocardiographyandcardiacmagnetic
resonanceimaging.JClinOncol.
2012;30(23):2876–2884.
28.YuAF,RaikhelkarJ,ZaborEC,etal.Twodimensionalspeckletrackingechocardiography
detectssubclinicalleftventricularsystolic
dysfunctionamongadultsurvivorsofchildhood,
Adolescent,andyoungadultcancer.BiomedRes
Int.2016;2016:9363951.
29.ArmenianSH,HudsonMM,MulderRL,etal.
Recommendationsforcardiomyopathy
surveillanceforsurvivorsofchildhoodcancer:a
reportfromtheinternationallateeffectsof
childhoodcancerguidelineharmonization
group.LancetOncol.2015;16(3):e123–e136.
30.PignatelliRH,GhaziP,ReddySC,etal.
Abnormalmyocardialstrainindicesinchildren
receivinganthracyclinechemotherapy.Pediatr
Cardiol.2015;36(8):1610–1616.
31.YlanenK,PoutanenT,Savikurki-HeikkilaP,
Rinta-KiikkaI,EerolaA.VettenrantaK.Cardiac
magneticresonanceimagingintheevaluationof
